Joint antitrust enforcement policy: a first step, but questions remain

Area of Science:

• Health Law
• Antitrust Law
• Regulatory Policy

Background:

• The Department of Justice (DOJ) and Federal Trade Commission (FTC) are key federal agencies enforcing antitrust laws.
• Antitrust enforcement in the healthcare sector is crucial for maintaining fair competition and patient access.
• Previous guidance on healthcare antitrust matters may have lacked specificity or timely review processes.

Purpose of the Study:

• To inform healthcare providers and organizations about new antitrust enforcement policies.
• To highlight the availability of expedited review for proposed conduct in specific healthcare areas.
• To explain the implications of joint DOJ and FTC statements on antitrust compliance.

Main Methods:

• Analysis of joint statements issued by the DOJ and FTC regarding healthcare antitrust.
• Identification of the six specific health care areas covered by the new policies.
• Review of the commitment to provide guidance within a 90-day timeframe for proposed actions.

Main Results:

• Joint issuance of "statements of antitrust enforcement policy" in six health care areas.
• Establishment of a 90-day response commitment for requests for specific guidance.
• The review process applies to proposed, not existing, conduct.

Conclusions:

• The new policies offer a streamlined and potentially attractive pathway for seeking antitrust clarity in healthcare.
• Healthcare organizations can benefit from understanding and utilizing this expedited review process.
• The joint approach by DOJ and FTC signifies a coordinated effort in healthcare antitrust oversight.